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Background: Despite having the third highest proportion of people aged 60 years and older in the world,
Germany has been recently reported as having the lowest prevalence of frailty of 15 European countries. The
objective of the study is to describe the prevalence of frailty in a large nationwide population-based sample and
examine associations with sociodemographic, social support and health characteristics.
Methods: We performed a cross-sectional analysis of the first wave of the German Health Interview and
Examination Survey for Adults (DEGS1) conducted 2008–2011. Participants were 1843 community-dwelling people
aged 65–79 years. Frailty and pre-frailty were defined, according to modified Fried criteria, as 3 and more or 1–2
respectively, of the following: exhaustion, low weight, low physical activity, low walking speed and low grip
strength. The Oslo-3 item Social Support Scale (OSS-3) was used. Patient Health Questionnaire (PHQ-9) measured
depressive symptoms and the Digit Symbol Substitution Test (DSST) measured cognition. Associations between
participants’ characteristics and frailty status were examined using unadjusted and adjusted multinomial logistic
regression models estimating relative risk ratios (RRR) of frailty and pre-frailty.
Results: The prevalence of frailty among women was 2.8% (CI 1.8-4.3) and pre-frailty 40.4% (CI 36.3-44.7) and among
men was 2.3% (CI 1.3-4.1) and 36.9% (CI 32.7-41.3) respectively. Independent determinants of frailty, from unadjusted
models, included older age, low socioeconomic status, poor social support, lower cognitive function and a history of
falls. In adjusted models current depressive symptoms (RRR 12.86, CI 4.47-37.03), polypharmacy (RRR 7.78, CI 2.92-20.72)
and poor hearing (RRR 5.38, CI 2.17-13.35) were statistically significantly associated with frailty.
Conclusions: Frailty prevalence is relatively low among community-dwelling older adults in Germany. Modifiable
characteristics like low physical activity provide relevant targets for individual and population-level frailty detection
and intervention strategies.
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The complex condition of frailty continues to gain in-
creased attention in the search to improve healthy life
expectancies for aging populations and healthcare for
older people. Frailty develops as a result of age-related
decline in various physiological systems leading to a
state of vulnerability and impaired ability to adapt to ex-
ternal stressors and an increased risk of dependency and
adverse outcomes [1]. Recent findings from the Survey* Correspondence: FuchsJ@rki.de
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wave 4 (2010–11) report that Germany, a country with
the third highest proportion of people aged 60 years and
older in the world [2], has the lowest prevalence of
frailty among 15 European countries [3]. Prevalence esti-
mates for frailty for people aged 50 years and older were
less than 1% for women and men in Germany and were
calculated within the context of activity limitation using
the SHARE-Frailty Index (FI) [3]. For those aged
70 years, life expectancy estimates with frailty were very
low in Germany with men estimated as averaging
0.1 years (0.7% of life expectancy) and women 0.4 years. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ation of frailty and its correlates in Germany is needed
to improve our understanding of intrinsic and extrinsic
factors associated with frailty and resilience that main-
tains individual well-being and independence [4].
Characterising population subgroups at risk of frailty
and relationships between frailty, social circumstances,
depressive symptoms, cognition and other health-related
factors will help identify modifiable intervention targets
which may reduce the burden of frailty for individuals
and help give directions for public health policy [5].
Using national health survey data we investigate sociode-
mographic and health determinants of frailty in a
population-based sample of community-dwelling older
adults in Germany.
Methods
The German Health Interview and Examination Survey
for Adults (DEGS) survey is part of the continuous
national health monitoring system carried out by the
Robert Koch Institute and provides representative data on
the health of adults in Germany at regular intervals [6].
The first wave (DEGS1) was conducted from November
2008 to December 2011 and the design, objectives and
methods have been described in detail elsewhere [6].
Briefly, DEGS1 has a mixed design permitting both cross-
sectional and longitudinal analyses. Persons aged 18–79
years randomly selected from local population registries
and former German National Health Interview and
Examination Survey participants in 1998 (GNHIES98)
[6] were invited to participate. In DEGS1, 8152 non-
institutionalised adults participated including 4193
first-time participants aged 18–79 years (response rate
42%) and 3959 previous participants of GNHIES98
aged 28–91 years (response rate 62%) [6].
DEGS1 included: standardised physician-administered
computer-assisted personal interview (CAPI) with details
on pre-existing physician-diagnosed health conditions;
self-administered questionnaires; a range of physical,
laboratory and other measurements; and robust data
collection of medicines use. Complete interview and
examination data for cross-sectional analyses were ini-
tially available for 7116 participants aged 18–79 years
[6]. One participant was later excluded from all further
analyses following withdrawal of informed consent. For
this study we focused on older adults, those aged 65–79
years with interview and examination data (n = 1853).
Participants whose frailty status could not be determined
due to missing data on three or more of the five items
used to measure frailty [7] were excluded (n = 10).There-
fore, the final study sample was 1843 participants.
Frailty was defined and measured based on modified
criteria used by Fried and colleagues in the Cardiovascular
Health Study [7]; the most frequently used method forquantifying frailty in population-based studies [8]. Partici-
pants with three or more of the following characteristics:
self-reported exhaustion, low weight, low physical activity,
low walking speed and low grip strength were classified as
frail [7]. Participants fulfilling one or two of the criteria
were classified as ‘pre-frail’ and ‘non-frail’ if they fulfilled
none. Similar to others [5,9], the measurement tools used
to characterise the individual components of frailty were
slightly adapted due to data availability and were deter-
mined as follows:
Self-reported exhaustion
Exhaustion was measured using a single item from the
validated German language version of the Medical Out-
come Short Form-36 (SF-36) [10]. Participants were
asked: ‘How much of the time during the past four
weeks did you have a lot of energy?’ Those responding
‘none’ or ‘little of the time’ were classified as having ex-
haustion consistent with other studies [11,12].
Low weight
No question related to unintentional weight loss was
available in DEGS1. We used Body Mass Index (BMI) as
an alternative consistent with others [9,13,14]. Those
with a BMI of less than 23 were considered low weight
akin to European studies investigating frailty [9,13] and
taking into account contemporary obesity prevalence
among older adults in Germany.
Low physical activity
Standardised questions related to physical activity and
sports were included in DEGS1 [15]. Participants report-
ing performing no sports in the previous three months
and no physical activity on any day of the week requiring
the person to start to sweat or get out of breath were
classified as having low physical activity.
Low walking speed
The timed up and go test is a reliable and valid test with
a standardised protocol for quantifying functional mobility
[16]. Participants taking 15 seconds or more were classi-
fied as having a low walking speed. This cut point has
demonstrated 100% specificity for identifying all pre-frail
or frail individuals according to Fried’s criteria in a large
cohort of older people [17].
Low grip strength
Isometric grip strength was measured using a hand-held
dynamometer (Smedley, Scandidact, Denmark, 100 kg).
Two values were recorded for each hand. Maximum grip
strength from all attempts was used for analyses. Low
grip strength was determined using sex and BMI specific
cut points specified by Fried and colleagues [7]. Few par-
ticipants had valid grip strength measures but missing
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strength was determined using established grip strength
values for sarcopenia (<20 kg for women and <30 kg for
men) consistent with others [5].
Socio-demographic variables included age, sex and living
alone. Socioeconomic status (SES) was classified as low,
middle and high using an established index including in-
formation on education, professional status and household
income [6]. Self-perceived levels of social support were
assessed using the Oslo-3 Social Support Scale (OSS-3)
with poor social support defined as <9 points (range
3–14) [18]. Additionally, participants were asked: ‘Do you
think you need more help in your daily routine than you
currently receive?’ Those responding ‘yes’ were classified
as having self-reported lack of help.
Current depressive symptoms within the last 2 weeks
were assessed using the 9-item depression module of
the German version of the Patient Health Question-
naire (PHQ-9) with those scoring 10 or more points
(range 0–27) as having current depressive symptoms
[19]. Cognitive function was assessed using the paper-
and-pencil Digit Symbol Substitution Test (DSST) from
the German version of the Wechsler Adult Intelligence
Scale, 3rd revision (WAIS-III) [20]. Participants are pro-
vided with a key showing unique graphic symbols corre-
sponding to numerical digits and copy symbols onto a
scoring sheet within 120 seconds (score range 0–133).
Self-rated health was measured using a standard item
from the SF-36 [10] and dichotomised as excellent/very
good/good versus fair/poor. Self-reported chronic dis-
eases (“Has a doctor ever diagnosed you as having..?”)
included: coronary heart disease (CHD) (including myo-
cardial infarction (MI), angina or other CHD), stroke,
heart failure, chronic renal disease, cancer, osteoarthritis,
rheumatoid arthritis and osteoporosis. Hypertension and
diabetes were determined based on self-reported history
of disease and intake of antihypertensive [21] or antidia-
betic medication [22]. Polypharmacy was defined as the
use of 5 and more prescription medicines in the 7 days
prior to examination [23]. History of falls was defined as
those reporting two or more falls in the past 12 months.
Self-reported poor hearing and poor vision were re-
corded. Health risk behaviours included current smoking
status and alcohol consumption (first item from Alcohol
Use Disorders Identification Test-Consumption [24]).
Statistical analyses
To describe the sample and the prevalence of frailty
participants’ characteristics were stratified by sex. To de-
scribe the sample according to their frailty status, pro-
portions, means, and respective 95% confidence intervals
(CI) are presented. To determine differences between (a)
non-frail versus pre-frail and (b) non-frail versus frail
groups, separate unadjusted multinomial regressionanalyses were conducted using the non-frail group as
the reference group. Then, all multinomial regression
models were adjusted for age (in years), sex and SES.
Both unadjusted and adjusted models, including relative
risk ratios (RRR) and 95% CIs are presented. Participants
with missing values were not included in analyses.
In order to report population estimates, all analyses
were conducted with a weighting factor which corrects
deviations in the sample from the population structure
(as of 31 Dec 2010) with regard to age, sex, region and
nationality, as well as community type and education.
Calculation of the weighting factor also considered re-
participation probability of GNHIES98 participants,
based on a logistic regression model. To take into ac-
count the weighting as well as the correlation of the par-
ticipants within a community, the confidence intervals
were determined with complex samples procedures in
SPSS-20 or survey procedures in STATA 12.1.
Ethics
DEGS1 was approved by the Charité-Universitaetsmedizin
Berlin ethics committee (No. EA2/047/08) and conducted
according to guidelines provided by the Federal and
State Commissioners for Data Protection. Participants
provided written informed consent prior to interview
and examination.
Results
Table 1 presents summary characteristics of study partic-
ipants. Table 2 presents the prevalence of frailty and its
components by sex: 2.3% of men and 2.8% of women
were frail, 36.9% of men and 40.4% of women were pref-
rail. Frailty status did not differ statistically significantly
between women and men. Low physical activity (men
24.1%, women 21.1%) and low grip strength (men:
10.8%, women: 12.6%) were the most common frailty
components for both women and men. With regard to
frailty components, women were significantly more
likely to have low weight.
Table 3 shows the results of the unadjusted and adjusted
multinomial regression models of associations between
participants’ characteristics and frailty status. Significant
associations were found for all variables except sex and liv-
ing alone. Associations were consistent across unadjusted
and adjusted models. Frail participants were older, were
more likely to have low SES and poor social support, more
often reported they lacked help, more often had current
depressive symptoms and had lower mean DSST scores
compared to non-frail participants. In addition, frail par-
ticipants reported worse self-reported health, more
chronic diseases, polypharmacy, more falls in the past
12 months, poor hearing, poor vision and reported not
consuming alcohol compared to non-frail participants.
The directional associations between non-frail and pre-
Table 1 Characteristics of German Health and Examination Survey 2008–2011 (DEGS1) participants aged 65–79 years
included in this study
Men (n = 919) Women (n = 924) Total (n = 1843)
Age groups in years (%, CI)
65-69 36.3 (32.6-40.1) 33.6 (30.2-37.3) 34.8 (32.4-37.4)
70-74 43.2 (39.2-47.2) 42.9 (39.0-46.9) 43.0 (40.1-46.0)
75-79 20.6 (17.5-24.0) 23.4 (20.0-27.2) 22.1 (19.6-24.9)
Socioeconomic status (SES) (%, CI)
low 21.7 (17.9-26.2) 29.1 (24.7-33.9) 25.7 (22.3-29.4)
medium 57.3 (52.8-61.7) 61.7 (57.2-66.0) 59.7 (56.1-63.1)
high 21.0 (17.7-24.7) 9.2 (7.2-11.6) 14.6 (12.6-17.0)
Living alone (%, CI) 9.6 (7.3-12.6) 34.0 (29.8-38.4) 22.8 (20.1-25.7)
Poor social support (%, CI) 16.8 (13.3-21.0) 16.2 (13.1-19.9) 16.5 (14.1-19.2)
Self-reported lack of help (%, CI) 2.0 (1.3-3.1) 8.2 (6.2-10.8) 5.3 (4.2-6.8)
Current depressive symptoms (%, CI) 4.2 (2.8-6.2) 7.3 (5.2-10.2) 5.9 (4.5-7.6)
Digit Symbol Substitution Test (mean score; CI) 42.6 (41.3-43.9) 45.0 (43.6-46.5) 43.9 (42.9-44.9)
Self-rated health (fair/poor) (%, CI) 27.4 (23.4-31.8) 28.9 (25.1-33.2) 28.2 (25.4-31.3)
Chronic diseases (%, CI)
coronary heart disease 27.6 (23.7-31.8) 14.5 (11.9-17.6) 20.6 (18.2-23.2)
stroke 7.2 (5.1-10.0) 6.0 (4.2-8.4) 6.5 (5.1-8.4)
heart failure 13.2 (10.2-16.9) 12.3 (9.5-15.9) 12.7 (10.5-15.4)
hypertension 70.3 (65.9-74.4) 71.6 (68.1-74.9) 71.0 (68.2-73.7)
diabetes 21.0 (17.5-25.0) 18.6 (15.4-22.2) 19.7 (17.3-22.3)
chronic renal disease 3.2 (2.2-4.8) 5.0 (3.3-7.5) 4.2 (3.0-5.7)
cancer 15.8 (13.2-18.9) 14.6 (11.9-17.8) 15.2 (13.2-17.4)
osteoarthritis 32.1 (28.3-36.2) 51.6 (47.7-55.4) 42.6 (39.9-45.3)
rheumatoid arthritis 5.0 (3.0-8.2) 4.3 (3.0-6.0) 4.6 (3.4-6.1)
osteoporosis 3.5 (2.4-5.3) 23.2 (19.4-27.5) 14.1 (12.0-16.5)
Mean number of chronic diseases (CI) 2.0 (1.8-2.1) 2.2 (2.1-2.3) (2.1 2.0-2.2)
Number of chronic diseases (%, CI)
none 12.5 (9.7-15.9) 6.8 (5.1-8.9) 9.4 (7.7-11.4)
1 28.0 (24.4-31.9) 27.1 (23.4-31.2) 27.5 (24.9-30.2)
2 29.8 (25.9-34.0) 30.6 (26.8-34.8) 30.2 (27.5-33.1)
3 or more 29.7 (25.7-34.0) 35.5 (31.5-39.7) 32.8 (29.8-36.1)
Polypharmacy (≥5 prescribed medicines) (%) 42.1 (37.8-46.5) 50.5 (46.6-54.3) 46.6 (43.7-49.5)
Falls (≥2) in past 12 months (%, CI) 6.1 (4.3-8.5) 10.5 (8.2-13.4) 8.5 (6.9-10.3)
Poor hearing (%, CI) 1.2 (0.6-2.2) 6.1 (4.2-8.7) 3.8 (2.8-5.3)
Poor vision (%, CI) 7.4 (5.5-9.8) 5.6 (4.0-7.8) 6.4 (5.0-8.1)
Health risk behaviours (%, CI)
body mass index (BMI), kg/m2
underweight (BMI < 18.5) 0.1 (0.0-0.4) 1.3 (0.4-4.3) 0.7 (0.2-2.3)
normal (BMI 18.5 < 25) 17.0 (14.2-20.2) 22.2 (19.2-25.4) 19.7 (17.7-21.9)
overweight (BMI 25 to <30) 51.4 (46.9-55.8) 37.7 (33.9-41.8) 44.1 (41.2-46.9)
obese (BMI≥ 30) 31.6 (27.2-36.4) 38.9 (35.0-42.9) 35.5 (32.4-38.7)
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Table 1 Characteristics of German Health and Examination Survey 2008–2011 (DEGS1) participants aged 65–79 years
included in this study (Continued)
currently smoking 10.9 (8.6-13.7) 8.6 (6.5-11.3) 9.7 (8.1-11.4)
current alcohol consumption 91.4 (88.6-93.6) 77.5 (73.2-81.3) 84.0 (81.2-86.5)
Figures are weighted population estimates expressed in per cent unless otherwise indicated.
CI: 95% confidence interval.
Not all percentages add to 100 due to rounding error.
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non-frail and frail participants, although RRRs were lower.
However, there were two exceptions: (a) there was no sig-
nificant association between non-frail and pre-frail groups
for poor hearing and (b) pre-frail participants reported
more frequently currently smoking compared to non-frail
and frail participants.
Discussion
Our prevalence estimates of frailty (2.6%) and pre-frailty
(38.8%) are lower than most German, European and
international studies, using Fried criteria to define frailty.
For example, findings from the SHARE cohort (wave 1
in 2004) estimated 12.1% of people aged 65 years as frail
in Germany [25]. In the SHARE study, frailty was mea-
sured using the SHARE-FI, an instrument based on
Fried criteria [7] but using different components e.g.
walking speed was measured by self-reported items
related to mobility limitations and not objective meas-
urement such as gait speed or the timed up and go.
DEGS1 included only participants aged 65 to 79 years
and no home visits were offered. This might have re-
sulted in the low estimates of frailty. In contrast, the
SHARE study has no upper age limit for participant in-
clusion and incorporates data collection from home
visits. These differences in study design, participantTable 2 Prevalence of frailty and pre-frailty and its componen






self-reported exhaustion 5.5 (3.7-8.1)
low weighta 4.7 (3.1-7.0)
low physical activity 24.1 (20.2-28.4)
low walking speedb 6.9 (4.9-9.5)
low grip strength 10.8 (8.3-13.9)
Figures are weighted population estimates expressed in per cent unless otherwise
CI: 95% confidence interval.
Not all percentages add to 100 due to rounding error.
aBody mass index < 23.
bTimed up and go test 15 seconds or more.inclusion criteria and heterogeneity of instruments used
to operationalise frailty [5,26] highlight that careful at-
tention is required to make meaningful comparisons be-
tween frailty prevalence studies. However, our findings
are comparable the Lausanne Cohort (Lc65+) longitu-
dinal study using similar methods of data collection at a
study centre and reporting 2.5% of participants as frail
and 26.5% as pre-frailty [27], albeit in a slightly younger
sample (age range 65–70 years) than our study. In a sys-
tematic review comparing and pooling international
frailty prevalence data, although estimates varied widely,
the overall weighted average prevalence of frailty was
9.9% (range 4.0%-17.0%) in community-dwelling adults
aged 65 years and over using definitions of frailty based
on Fried criteria [26]. Therefore, we cautiously interpret
our prevalence estimates as relatively low in an inter-
national context.
We found no statistically significant associations be-
tween sex and frailty contrasting with numerous studies
reporting higher frailty prevalence among women [26].
Our non-significant findings are likely a result of the low
prevalence of frailty in our study and may represent Type
II error. Women demonstrated higher prevalence of all
frailty components except low physical activity. The frailty
phenotype is intrinsically connected with muscle strength
measurement, both in terms of grip strength and walkingts
Women (n = 924)% (CI) Total (n = 1843)% (CI)
2.8 (1.8-4.3) 2.6 (1.8-3.6)
40.4 (36.3-44.7) 38.8 (35.9-41.8)
56.7 (52.6-60.8) 58.6 (55.6-61.5)
9.7 (7.5-12.5) 7.8 (6.2-9.6)
10.3 (8.0-13.2) 7.7 (6.2-9.5)
21.1 (17.7-25.0) 22.5 (19.8-25.5)
8.9 (6.5-12.0) 8.0 (6.3-10.0)
12.6 (9.7-16.2) 11.8 (9.6-14.3)
indicated.
Table 3 Prevalence and associations between participants’ characteristics and frailty status in unadjusted and adjusted
multinomial regression models
Unadjusted model Adjusted modela
Not frail versus Not frail versus
Non-frail Pre-frail Frail Pre-frail Frail Pre-frail Frail
n = 1139 n = 659 n = 45
% % % RRR (CI) RRR (CI) RRR (CI) RRR (CI)
Age groups in years
65-69 36.8 33.1 17.9 Ref. Ref. Ref. Ref.
70-74 45.0 40.3 40.3 0.99 (0.77-1.29) 1.85 (0.69-4.91) 0.94 (0.72-1.22)b 1.64 (0.64-4.18)b
75-79 18.3 26.7 41.8 1.62 (1.15-2.29) 4.72 (1.79-12.41) 1.49 (1.04-2.13)b 4.03 (1.63-9.98)b
Sex
men 47.9 43.9 41.6 Ref. Ref. Ref. Ref.
women 52.1 56.1 58.4 1.17 (0.90-1.52) 1.29 (0.61-2.76) 1.08 (0.82-1.41)c 1.05 (0.50-2.19)c
Socioeconomic status (SES)
low 19.9 32.4 56.7 Ref. Ref. Ref. Ref.
medium 62.4 57.2 35.3 0.56 (0.41-0.78) 0.20 (0.10-0.40) 0.57 (0.41-0.79)d 0.21 (0.10-0.42)d
high 17.7 10.4 8.0 0.36 (0.24-0.54) 0.16 (0.04-0.66) 0.38 (0.25-0.58)d 0.19 (0.05-0.75)d
Living alone
no 78.2 76.2 69.8 Ref. Ref. Ref. Ref.
yes 21.8 23.8 30.2 1.12 (0.84-1.49) 1.55 (0.73-3.31) 1.02 (0.76-1.37) 1.31 (0.57-3.01)
Poor social support
no 88.3 78.1 56.0 Ref. Ref. Ref. Ref.
yes 11.7 21.9 44.0 2.12 (1.43-3.15) 5.94 (2.75-12.83) 1.99 (1.34-2.95) 4.96 (2.21-11.12)
Self-reported lack of help
no 97.6 91.6 76.1 Ref. Ref. Ref. Ref.
yes 2.4 8.4 23.9 3.67 (2.11-6.38) 12.51 (4.97-31.45) 3.50 (1.96-6.25) 12.18 (4.73-31.35)
Current depressive symptoms
no 97.2 90.7 73.5 Ref. Ref. Ref. Ref.
yes 2.8 9.3 26.5 3.55 (2.04-6.16) 12.47 (5.09-30.56) 3.64 (2.03-6.53) 12.86 (4.47-37.03)
Mean Digit Symbol Substitution Test 46.0 41.4 32.6 0.98 (0.97-0.98) 0.93 (0.90-0.95) 0.98 (0.97-0.99)e 0.94 (0.91-0.97)f
Self-reported health (fair/ poor)
no 79.3 63.5 22.6 Ref. Ref. Ref. Ref.
yes 20.7 36.5 77.4 2.20 (1.67-2.92) 13.16 (5.21-33.20) 2.21 (1.66-2.94) 13.30 (5.15-34.31)
Chronic diseasesg
mean 1.9 2.3 3.3 1.24 (1.13-1.36) 1.94 (1.57-2.40) 1.23 (1.11-1.35) 1.92 (1.56-2.35)
3 or more diseases
no 73.2 60.0 39.7 Ref. Ref. Ref. Ref.
yes 26.9 40.0 60.3 1.82 (1.42-2.33) 4.14 (1.91-8.97) 1.76 (1.63-2.26) 3.79 (1.72-8.31)
Polypharmacy
no 58.5 48.3 14.2 Ref. Ref. Ref. Ref.
yes 41.5 51.7 85.8 1.51 (1.20-1.89) 8.54 (3.35-21.77) 1.47 (1.17-1.86) 7.78 (2.92-20.72)
Falls (≥2) in past 12 months
no 93.8 88.9 79.2 Ref. Ref. Ref. Ref.
yes 6.2 11.1 20.8 1.89 (1.16-3.08) 3.97 (1.53-10.26) 1.84 (1.15-2.96) 4.31 (1.65-11.26)
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Table 3 Prevalence and associations between participants’ characteristics and frailty status in unadjusted and adjusted
multinomial regression models (Continued)
Poor hearing
no 94.4 93.6 74.9 Ref. Ref. Ref. Ref.
yes 5.6 6.4 25.1 1.15 (0.71-1.87) 5.69 (2.27-14.23) 1.14 (0.71-1.84) 5.38 (2.17-13.35)
Poor vision
no 97.7 91.4 88.7 Ref. Ref. Ref. Ref.
yes 2.3 5.6 11.3 2.50 (1.30-4.79) 5.31 (1.53-18.42) 2.24 (1.20-4.14) 3.81 (1.09-13.34)
Currently smoking
no 91.9 87.9 91.5 Ref. Ref. Ref. Ref.
yes 8.1 12.1 8.5 1.56 (1.02-2.38) 1.06 (0.25-4.42) 1.65 (1.08-2.50) 1.32 (0.30-5.81)
Current alcohol consumption
no 12.7 20.6 38.2 Ref. Ref. Ref. Ref.
yes 87.3 79.4 61.8 0.56 (0.41-0.77) 0.24 (0.11-0.51) 0.61 (0.44-0.85) 0.30 (0.11-0.82)
Figures are weighted population estimates expressed in per cent unless otherwise indicated. Not all percentages add to 100 due to rounding error.
RRR: relative risk ratio.
CI: 95% confidence interval.
Ref.: reference category.
aMultinomial logistic regression models for each variable adjusted for age, sex and low socio economic status (SES) unless otherwise stated, badjusted for sex and
SES only, cadjusted for age and SES only, dadjusted for age and sex only, ealternatively adjusted for age, sex, education (not SES) RRR = 0.98, CI: 0.97-0.99,
falternatively adjusted for age, sex, education (not SES) RRR = 0.92, CI: 0.90-0.95, gTen conditions included coronary heart disease, stroke, heart failure,
hypertension, diabetes, chronic renal disease, cancer, osteoarthritis, rheumatoid arthritis and osteoporosis.
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tors [28] may underpin sex differences in frailty prevalence.
Alternatively, our non-significant findings between sex and
frailty may be explained by women performing higher levels
of physical activity (as they reported), thereby buffering the
relative sex differences in sarcopenia between ages 65–79
years and delaying the age of onset of frailty to later life i.e.
beyond the upper age limit of our study.
We found an association between SES and frailty
indicating a social gradient in frailty, which may be me-
diated by conditions that occur more frequently among
disadvantaged individuals [3,5]. Although previous
studies have reported associations between living alone
and frailty [9], we found no such association. However,
we found strong associations between low levels of so-
cial support and self-reported lack of help and frailty
highlighting that these factors may contribute more to
frailty status than living alone in Germany.
Consistent with previous research we found significant
relationships between current depressive symptoms
[9,11,29] and lower cognition [9,29,30] and frailty. Un-
surprisingly, we found a clear incremental association
between the number of chronic diseases, pre-frailty and
frailty. Polypharmacy showed a stronger relationship to
frailty in terms of relative risk than having more chronic
diseases therefore it may be a relevant modifiable clinical
target to reduce frailty. Poor hearing was strongly associ-
ated with frailty, but not with pre-frailty status in our
study. We found smoking status was particularly associ-
ated with pre-frailty and lower alcohol consumption was
associated with being frail consistent with others [5,9].Low physical activity and low grip strength were the
two most common components of frailty signposting
that methods to improve physical activity and muscle
strength need greater attention in research examining
the frailty burden at individual and population levels.
Other relevant targets for specific frailty detection and
intervention studies relate to socioeconomic status, social
support, depressive symptoms, cognition, falls, polyphar-
macy and poor hearing.
Our study has a number of strengths and limitations.
The standardised methods used in DEGS1 ensure high
quality data collection in a representative sample of the
German population. However, the survey focus is on the
community-dwelling population; excluding residents of
institutions and those unable to visit the study centres
who are more likely to be frail and therefore our findings
may under-estimate frailty at the population level. We
used Fried and colleagues’ criteria to classify frailty; how-
ever, we made minor modifications to the original compo-
nents due to data availability. We recognise complex
relationships exist between BMI, obesity and frailty status
and our methods of using BMI as a proxy for unintentional
weight loss, although consistent with numerous others
[9,13,14] may have resulted in misclassification of some
older adults with obesity as not frail. Our results should
be interpreted with caution as the absolute numbers of
participants with frailty was low and restricted analyses.
For example, we were unable to undertake more detailed
sex-specific analyses. However, recognising the importance
of age, sex and SES status from previous frailty studies
[5,7,9] we performed restricted multinomial regression
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ered only cross-sectional relationships between participants’
characteristics and frailty. Temporal relationships between
frailty onset and outcomes were not examined.
Conclusions
The community-dwelling German population aged 65–79
years demonstrates intriguingly low levels of frailty at the
end of the 2010’s and warrants further examination with
epidemiological studies using consistent methods to facili-
tate comparisons of data and data pooling. We found sig-
nificant associations between participants’ characteristics
and levels of frailty. Modifiable characteristics might pro-
vide clinically relevant targets for interventions; particularly
in the case of poor social support, current depressive
symptoms, cognition, falls prevention, polypharmacy and
poor hearing.
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